DRDATSONS

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 12, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has informed the Exchange that due to unfavorable market circumstances, the Company has decided to defer the issue of FCCBs till further notice.

Finaventure Capital Limited has submitted to the Exchange vide letter dated February 11, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 04, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 02, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated February 20, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated February 26, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 02, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide letter dated February 26, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange vide its letter dated March 02, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Aanjaneya Lifecare Limited has submitted to the Exchange vide its letter dated February 26, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 05, 2013 inter alia, have decided that the date of opening of issuance of FCCB up to USD 75 million is on March 12, 2013.

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated February 19, 2013, titled "Aanjaneya Lifecare wins the prestigious Corporate Governance and Sustainability Vision Awards 2013".

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated February 09, 2013, titled "Global Recognition For Aanjaneya Lifecare, Enters The Elite List of Golden Peacock Awards, Receives "Golden Peacock National Quality Award".

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated February 08, 2013, titled "Aanjaneya Lifecare Limited net profit up in First 9 months".

Aanjaneya Lifecare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended December 31,2012.

Finaventure Capital Ltd has submitted to the Exchange vide its letter dated February 01, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated January 31, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange a copy of Disclosures, in respect of details of shares under Regulation 13(6) of SEBI (Prohibition of Insider Trading regulations). 1992.

Kannan Vishwanath has submitted to the Exchange vide its letter dated January 22, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has informed the Exchange regarding the following : "Aanjaneya Lifecare Limited [ALL] have incorporated Wholly owned Subsidiary named "AANJ Pharmalabs Limited FZE" in Dubai AirPort Free Zone a Company incorporated in UAE, by way of subscribing 100% ordinary share capital of the said Subsidiary Company".

Finaventure Capital Limited has submitted to the Exchange vide letter dated January 18, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has informed the Exchange that "with reference to the press release bearing no F.NO.11(1)/2012-FIPB, Government of India, Ministry of Finance, Department of economic Affairs (FIPB Unit) Dated January 11, 2013 that the proposal of Foreign Currency Convertible Bonds Amounting to Rs. 405.00 Crore ( Four Hundred Five Crore only ) of our company have been recommended by FIPB and approved by Ministry of finance government of India".

Aanjaneya Lifecare Limited has informed the Exchange that the company begins the Fiscal on a Strong Note, bags coveted "Asia's Emerging Pharmaceutical Company on Innovations Award 2013" at Assocham's 10th Knowledge Millennium Summit. The Department of Science & Technology, Ministry of Science & Technology Government of India. Organised by The Associated Chambers of Commerce and Industry of India (ASSOCHAM).

Finaventure Capital Limited has submitted to the Exchange vide letter dated January 04, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated January 01, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated December 28, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated December 14, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 .

Finaventure Capital Ltd has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated December 18, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide letter dated December 19, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Kannan Vishwanath has submitted to the Exchange vide letter dated December 14, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for acquisition of 34850 shares.

Kannan Vishwanath has submitted to the Exchange vide letter dated December 12, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for acquisition of 12000 shares.

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated December 13, 2012, titled "Aanjaneya Lifecare Limited ranked No 2 Industry wise & 9th Position in the Asia-Pacific region at The Global Investor Relations Summit".

Finaventure Capital Ltd has submitted to the Exchange vide letter dated December 10, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr.Kannan Vishwanath has submitted to the Exchange vide letter dated December 10, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr.Kannan Vishwanath has submitted to the Exchange vide letter dated December 04, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Ltd has submitted to the Exchange vide letter dated December 04, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated November 26, 2012, titled "Aanjaneya Lifecare Ltd Annual Report wins Gold Certification at LACP Florida 2012".

Finaventure Capital Ltd has submitted to the Exchange vide letter dated November 20, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange vide letter dated November 19, 2012 a copy of Results of Postal Ballot conducted by the Company and as declared by the Chairman based on the Scrutinizer's Report.

Aanjaneya Lifecare Limited has informed the Exchange regarding a press release dated November 09, 2012, titled "Aanjaneya Lifecare Limited net profit up 19% in First Half".

Aanjaneya Lifecare Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30, 2012.

Finaventure Capital Ltd has submitted to the Exchange vide its letter dated October 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated November 01, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated October 20, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange a copy of notice pursuant to Section 192A of the Companies Act, 1956, read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, in respect of the resolutions to be passed through Postal Ballot : (1) To raise funds through warrants, convertible debentures, Foreign Currency Convertible Bonds (FCCBs), Foreign Currency Convertible Notes (FCCNs), Global Depository Receipts (GDRs) and/or American Depository Receipts (ADRs), Secured Premium Notes (SPNs) and/or other financial instruments (OFIs) Convertible into Equity Sh

Aanjaneya Lifecare Limited has informed the Exchange regarding the Outcome of the Meeting of the Board of Directors of the Company held on October 16, 2012.

Finaventure Capital Limited has submitted to the Exchange vide letter dated October 12, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange a copy of the Minutes of the Annual General Meeting of the Company held on September 10, 2012.